instruction
stringlengths 39
316
| response
stringlengths 121
336
| text
stringlengths 194
685
|
|---|---|---|
What’s the median PFS rate for patients receiving Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: What’s the median PFS rate for patients receiving Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
Could you provide the median Progression-Free Survival rate for patients treated with Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: Could you provide the median Progression-Free Survival rate for patients treated with Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
What is the median rate of Progression-Free Survival in patients who have been treated with Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: What is the median rate of Progression-Free Survival in patients who have been treated with Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
Can you inform me about the median PFS rate in patients that were treated with Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: Can you inform me about the median PFS rate in patients that were treated with Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
What is the median PFS rate for patients that have undergone Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: What is the median PFS rate for patients that have undergone Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
Could you tell me the median Progression-Free Survival rate for patients who received Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: Could you tell me the median Progression-Free Survival rate for patients who received Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
What’s the median rate of PFS in patients treated with Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: What’s the median rate of PFS in patients treated with Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
Can you share the median Progression-Free Survival rate in patients who have received Pomalidomide+Dexamethasone regimen? | Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. | ### Instruction: Can you share the median Progression-Free Survival rate in patients who have received Pomalidomide+Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide+Dexamethasone have a median Progression-Free Survival (PFS) rate of 7 months, with a 95% CI of None. |
Can you tell me the median PFS for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Can you tell me the median PFS for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What’s the median PFS associated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What’s the median PFS associated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Could you provide the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Could you provide the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
I’d like to know the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd). | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: I’d like to know the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd).
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Do you have information on the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Do you have information on the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What is the median progression-free survival (PFS) for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What is the median progression-free survival (PFS) for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Can you inform me about the median PFS for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Can you inform me about the median PFS for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
I’m interested in the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd). | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: I’m interested in the median PFS of Carfilzomib+Cyclophosphamide+Dexamethasone (KCd).
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Could you tell me the median PFS for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Could you tell me the median PFS for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What is the median PFS rate for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What is the median PFS rate for Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What is the median Progression-Free Survival (PFS) rate in patients treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What is the median Progression-Free Survival (PFS) rate in patients treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What is the median PFS rate in patients who have undergone Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What is the median PFS rate in patients who have undergone Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Can you tell me the median Progression-Free Survival rate in patients who were treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Can you tell me the median Progression-Free Survival rate in patients who were treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What’s the median PFS rate for patients receiving Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What’s the median PFS rate for patients receiving Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Could you provide the median Progression-Free Survival rate for patients treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Could you provide the median Progression-Free Survival rate for patients treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What is the median rate of Progression-Free Survival in patients who have been treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What is the median rate of Progression-Free Survival in patients who have been treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Can you inform me about the median PFS rate in patients that were treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Can you inform me about the median PFS rate in patients that were treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What is the median PFS rate for patients that have undergone Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What is the median PFS rate for patients that have undergone Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Could you tell me the median Progression-Free Survival rate for patients who received Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Could you tell me the median Progression-Free Survival rate for patients who received Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
What’s the median rate of PFS in patients treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: What’s the median rate of PFS in patients treated with Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Can you share the median Progression-Free Survival rate in patients who have received Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen? | Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. | ### Instruction: Can you share the median Progression-Free Survival rate in patients who have received Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) regimen?
### Response: Patients treated with the Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) have a median Progression-Free Survival (PFS) rate of 11.7 months, with a 95% CI of None. |
Can you tell me the median PFS for Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Can you tell me the median PFS for Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What’s the median PFS associated with Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What’s the median PFS associated with Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Could you provide the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Could you provide the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
I’d like to know the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd). | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: I’d like to know the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd).
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Do you have information on the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Do you have information on the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What is the median progression-free survival (PFS) for Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What is the median progression-free survival (PFS) for Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Can you inform me about the median PFS for Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Can you inform me about the median PFS for Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
I’m interested in the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd). | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: I’m interested in the median PFS of Cyclophosphamide+Velcade+Dexamethasone (CVd).
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Could you tell me the median PFS for Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Could you tell me the median PFS for Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What is the median PFS rate for Cyclophosphamide+Velcade+Dexamethasone (CVd)? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What is the median PFS rate for Cyclophosphamide+Velcade+Dexamethasone (CVd)?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What is the median Progression-Free Survival (PFS) rate in patients treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What is the median Progression-Free Survival (PFS) rate in patients treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What is the median PFS rate in patients who have undergone Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What is the median PFS rate in patients who have undergone Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Can you tell me the median Progression-Free Survival rate in patients who were treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Can you tell me the median Progression-Free Survival rate in patients who were treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What’s the median PFS rate for patients receiving Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What’s the median PFS rate for patients receiving Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Could you provide the median Progression-Free Survival rate for patients treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Could you provide the median Progression-Free Survival rate for patients treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What is the median rate of Progression-Free Survival in patients who have been treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What is the median rate of Progression-Free Survival in patients who have been treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Can you inform me about the median PFS rate in patients that were treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Can you inform me about the median PFS rate in patients that were treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What is the median PFS rate for patients that have undergone Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What is the median PFS rate for patients that have undergone Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Could you tell me the median Progression-Free Survival rate for patients who received Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Could you tell me the median Progression-Free Survival rate for patients who received Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
What’s the median rate of PFS in patients treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: What’s the median rate of PFS in patients treated with Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Can you share the median Progression-Free Survival rate in patients who have received Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen? | Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. | ### Instruction: Can you share the median Progression-Free Survival rate in patients who have received Cyclophosphamide+Velcade+Dexamethasone (CVd) regimen?
### Response: Patients treated with the Cyclophosphamide+Velcade+Dexamethasone (CVd) have a median Progression-Free Survival (PFS) rate of 10.2 months, with a 95% CI of None. |
Can you tell me the median PFS for Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Can you tell me the median PFS for Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What’s the median PFS associated with Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What’s the median PFS associated with Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Could you provide the median PFS of Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Could you provide the median PFS of Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
I’d like to know the median PFS of Pomalidomide Plus Low-Dose Dexamethasone. | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: I’d like to know the median PFS of Pomalidomide Plus Low-Dose Dexamethasone.
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Do you have information on the median PFS of Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Do you have information on the median PFS of Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What is the median progression-free survival (PFS) for Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What is the median progression-free survival (PFS) for Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Can you inform me about the median PFS for Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Can you inform me about the median PFS for Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
I’m interested in the median PFS of Pomalidomide Plus Low-Dose Dexamethasone. | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: I’m interested in the median PFS of Pomalidomide Plus Low-Dose Dexamethasone.
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Could you tell me the median PFS for Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Could you tell me the median PFS for Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What is the median PFS rate for Pomalidomide Plus Low-Dose Dexamethasone? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What is the median PFS rate for Pomalidomide Plus Low-Dose Dexamethasone?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What is the median Progression-Free Survival (PFS) rate in patients treated with Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What is the median Progression-Free Survival (PFS) rate in patients treated with Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What is the median PFS rate in patients who have undergone Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What is the median PFS rate in patients who have undergone Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Can you tell me the median Progression-Free Survival rate in patients who were treated with Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Can you tell me the median Progression-Free Survival rate in patients who were treated with Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What’s the median PFS rate for patients receiving Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What’s the median PFS rate for patients receiving Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Could you provide the median Progression-Free Survival rate for patients treated with Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Could you provide the median Progression-Free Survival rate for patients treated with Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What is the median rate of Progression-Free Survival in patients who have been treated with Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What is the median rate of Progression-Free Survival in patients who have been treated with Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Can you inform me about the median PFS rate in patients that were treated with Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Can you inform me about the median PFS rate in patients that were treated with Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What is the median PFS rate for patients that have undergone Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What is the median PFS rate for patients that have undergone Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Could you tell me the median Progression-Free Survival rate for patients who received Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Could you tell me the median Progression-Free Survival rate for patients who received Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
What’s the median rate of PFS in patients treated with Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: What’s the median rate of PFS in patients treated with Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Can you share the median Progression-Free Survival rate in patients who have received Pomalidomide Plus Low-Dose Dexamethasone regimen? | Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). | ### Instruction: Can you share the median Progression-Free Survival rate in patients who have received Pomalidomide Plus Low-Dose Dexamethasone regimen?
### Response: Patients treated with the Pomalidomide Plus Low-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 4 months, with a 95% CI of (3.6, 4.7). |
Can you tell me the median PFS for High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Can you tell me the median PFS for High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What’s the median PFS associated with High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What’s the median PFS associated with High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Could you provide the median PFS of High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Could you provide the median PFS of High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
I’d like to know the median PFS of High-Dose Dexamethasone. | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: I’d like to know the median PFS of High-Dose Dexamethasone.
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Do you have information on the median PFS of High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Do you have information on the median PFS of High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What is the median progression-free survival (PFS) for High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What is the median progression-free survival (PFS) for High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Can you inform me about the median PFS for High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Can you inform me about the median PFS for High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
I’m interested in the median PFS of High-Dose Dexamethasone. | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: I’m interested in the median PFS of High-Dose Dexamethasone.
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Could you tell me the median PFS for High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Could you tell me the median PFS for High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What is the median PFS rate for High-Dose Dexamethasone? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What is the median PFS rate for High-Dose Dexamethasone?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What is the median Progression-Free Survival (PFS) rate in patients treated with High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What is the median Progression-Free Survival (PFS) rate in patients treated with High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What is the median PFS rate in patients who have undergone High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What is the median PFS rate in patients who have undergone High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Can you tell me the median Progression-Free Survival rate in patients who were treated with High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Can you tell me the median Progression-Free Survival rate in patients who were treated with High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What’s the median PFS rate for patients receiving High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What’s the median PFS rate for patients receiving High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Could you provide the median Progression-Free Survival rate for patients treated with High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Could you provide the median Progression-Free Survival rate for patients treated with High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What is the median rate of Progression-Free Survival in patients who have been treated with High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What is the median rate of Progression-Free Survival in patients who have been treated with High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Can you inform me about the median PFS rate in patients that were treated with High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Can you inform me about the median PFS rate in patients that were treated with High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What is the median PFS rate for patients that have undergone High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What is the median PFS rate for patients that have undergone High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Could you tell me the median Progression-Free Survival rate for patients who received High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Could you tell me the median Progression-Free Survival rate for patients who received High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
What’s the median rate of PFS in patients treated with High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: What’s the median rate of PFS in patients treated with High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Can you share the median Progression-Free Survival rate in patients who have received High-Dose Dexamethasone regimen? | Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). | ### Instruction: Can you share the median Progression-Free Survival rate in patients who have received High-Dose Dexamethasone regimen?
### Response: Patients treated with the High-Dose Dexamethasone have a median Progression-Free Survival (PFS) rate of 1.9 months, with a 95% CI of (1.9, 2.2). |
Can you tell me the median PFS for Lenalidomide Maintenance? | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: Can you tell me the median PFS for Lenalidomide Maintenance?
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
What’s the median PFS associated with Lenalidomide Maintenance? | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: What’s the median PFS associated with Lenalidomide Maintenance?
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
Could you provide the median PFS of Lenalidomide Maintenance? | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: Could you provide the median PFS of Lenalidomide Maintenance?
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
I’d like to know the median PFS of Lenalidomide Maintenance. | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: I’d like to know the median PFS of Lenalidomide Maintenance.
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
Do you have information on the median PFS of Lenalidomide Maintenance? | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: Do you have information on the median PFS of Lenalidomide Maintenance?
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
What is the median progression-free survival (PFS) for Lenalidomide Maintenance? | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: What is the median progression-free survival (PFS) for Lenalidomide Maintenance?
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
Can you inform me about the median PFS for Lenalidomide Maintenance? | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: Can you inform me about the median PFS for Lenalidomide Maintenance?
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
I’m interested in the median PFS of Lenalidomide Maintenance. | Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. | ### Instruction: I’m interested in the median PFS of Lenalidomide Maintenance.
### Response: Patients treated with the Lenalidomide Maintenance have a median Progression-Free Survival (PFS) rate of 41 months, with a 95% CI of None. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.